Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-03 Sale | 2024-04-05 4:30 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 10,451 | $4.95 | $51,732 | 0 (Direct) | View |
| 2024-04-02 Sale | 2024-04-02 4:58 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 150 | $4.9803 | $747 | 41,118 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 4:24 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,287 | $4.95 | $31,121 | 0 (Direct) | View |
| 2023-12-06 Sale | 2023-12-08 4:23 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,287 | $3.95 | $24,834 | 6,287 (Direct) | View |
| 2023-07-31 Sale | 2023-08-02 4:21 pm | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 7,348 | $3.95 | $29,025 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-31 Exercise | 2024-04-02 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 15,333 | $0 | 41,118 (Direct) | View |
| 2024-04-01 Tax Withholding | 2024-04-02 4:58 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 4,732 | $5.12 | 41,118 (Direct) | View |
| 2023-10-31 Exercise | 2023-11-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 18,875 | $0 | 31,449 (Direct) | View |
| 2023-11-01 Tax Withholding | 2023-11-02 4:52 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 6,301 | $2.22 | 31,449 (Direct) | View |
| 2023-03-31 Exercise | 2023-04-04 6:56 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 2,000 | $0 | 13,348 (Direct) | View |
| 2023-04-03 Tax Withholding | 2023-04-04 6:56 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 623 | $2.58 | 13,348 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 4:24 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-10-06 Option Award | 2022-10-11 4:38 pm | N/A 2032-10-05 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 87,500 | $0 | 87,500 (Direct) | View |
Ownership | 2022-07-11 5:15 pm | N/A 2027-07-07 | Allarity Therapeutics Inc. | ALLR | Roth David Director | 0 | $0 | 23,000 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:03 pm | N/A N/A | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 27,281 | $1.12 | 59,719 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 4:10 pm | N/A 2032-02-14 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 405,000 | $0 | 405,000 (Direct) | View |
| 2021-02-17 Option Award | 2021-02-19 4:13 pm | N/A 2031-02-16 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 119,000 | $0 | 119,000 (Direct) | View |
| 2020-02-13 Option Award | 2020-02-14 4:06 pm | N/A 2030-02-12 | Syros Pharmaceuticals Inc. | SYRS | Roth David Chief Medical Officer | 94,000 | $0 | 94,000 (Direct) | View |